Urgent need for defibrillators in public facilities, says Lam Thye
Alliance for a Safe Community chairman, Tan Sri Lee Lam Thye, said that sudden cardiac arrest (SCA) is a silent killer that can strike anyone, anywhere, at any time — whether at a shopping mall, a workplace, a sports facility or even on public transport.
'However, when an AED is used within the first few minutes, survival rates can be as high as 70 per cent. This is why AEDs must be readily accessible to the public, just like fire extinguishers.
'AEDs should be a mandatory fixture in all public facilities. This includes government buildings, transportation hubs, shopping malls, schools, sports complexes, and workplaces. Just as we require emergency exits and fire extinguishers, AEDs should be a non-negotiable safety measure,' he said in a statement today.
However, he said the government should introduce regulations ensuring AEDs are installed and properly maintained, with clear signage indicating their location.
Lee also said that security personnel and staff at these facilities should receive basic cardiopulmonary resuscitation (CPR) and AED training to maximise their effectiveness in an emergency.
According to him, several countries, including Japan, Australia and the United Kingdom, have introduced laws requiring AEDs in public spaces and Malaysia should follow suit.
He said governments must play a leading role in expanding AED access through funding programmes, grants and partnerships with private organizations and work with local authorities to map out high-risk areas, besides ensuring AEDs are strategically placed where they are most needed.
'While AEDs are important, they are not cheap. AEDs can range from RM6,000 to RM25,000 depending on features, and also come with maintenance fees.
'AEDs need a change of batteries and AED pads every three to five years, depending on the models. As such, I wish to suggest a tax exemption initiative or subsidies to place AEDs in the public and to fix the ceiling price for AED consumables like batteries and AED pads,' he said.
At the same time, Lee also emphasised the need to create and enhance public awareness.
He said education campaigns should target all levels of society, and basic CPR and AED training should be included in school syllabuses to help people respond confidently during emergencies.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
2 days ago
- The Star
Apex court upholds Singapore Medical Council's conviction of doctor who gave patients unapproved hormones
SINGAPORE: A doctor who prescribed various unapproved hormones, including one made from desiccated pig thyroid glands, has failed in his appeal to the highest court to quash his convictions and sentences by the Singapore Medical Council (SMC). Instead, the conviction against Dr Ian Lee Pheng Lip, a general practitioner from Integrated Medicine Clinic, stands. His 18-month suspension begins in two weeks, and he had to pay S$50,000 – the cost of the appeal – to the SMC. The decision of the Court of Three Judges, comprising Chief Justice Sundaresh Menon, Justice of the Court of Appeal Tay Yong Kwang and Senior Judge Judith Prakash, to dismiss his appeal in respect of 17 charges of professional misconduct under the Medical Registration Act was delivered on July 8. The three judges felt that the disciplinary tribunal was correct to impose the sentences on Dr Lee, and that the aggregate sentence imposed 'was not manifestly excessive'. A complaints committee (CC) began probing Dr Lee on May 8, 2014, following a complaint by the SMC that he was offering non-mainstream services. This was after the Ministry of Health (MOH) notified the SMC of its concerns regarding Dr Lee's provision of various unapproved hormones to his patients. These were the following: >Erfa, a thyroid hormone preparation made from desiccated pig thyroid glands containing both the thyroxine (T4) and triiodothyronine(T3) forms of thyroid hormone, which Dr Lee prescribed on 41 occasions between late 2011 and early 2014 to eight patients. >Biest and Triest, custom compounded formulations containing a mixture of estrogens. Between late 2011 and early 2014, he prescribed Biest on 11 occasions to two patients, and Triest on three occasions to two patients. >Testosterone, a hormone produced by both males and females. >Progesterone, a female sex hormone which plays a crucial part in the menstrual cycle and the maintenance of pregnancy. Dr Lee faced two charges for his prescriptions of progesterone to two women, who had undergone hysterectomy. When Dr Lee's clinic licence expired on March 16, 2015, MOH did not grant a further renewal as he did not show he had the intention to wean his patients off the hormone replacements. MOH even found out that he was prescribing testosterone to patients who did not need it, nor did he have proper clinical documentation of the patients' testosterone deficiencies. As a result, a second letter of complaint was issued by the SMC on April 30, 2015. When invited to submit written explanations, Dr Lee generally took the position that he was entitled to prescribe the hormones to his patients. The CC sent a letter on Feb 12, 2018, informing him that it had ordered an inquiry to be held by a disciplinary tribunal. Dr Lee sought to challenge its decision and filed a motion with the High Court seeking to quash the inquiry. He argued that he suffered substantial prejudice from the 'inordinate delay' it had taken for his case to be referred to the tribunal, but he failed in his High Court judicial review bid to stop the probe against him. He appealed to the Court of Appeal but the court dismissed the appeal and upheld the High Court's decision. Following the lifting of the stay of proceedings, the SMC issued Dr Lee with 21 charges on April 22, 2021. SMC's case was that Erfa, Biest and Triest were 'non-evidence-based treatments' that could 'only be administered in the context of a formal and approved clinical trial'; and that Dr Lee offered to his patients a management plan or remedy that was not generally accepted by the medical profession. Two expert witnesses testified for SMC, and after the inquiry an oral hearing was convened on June 6, 2023, after the parties exchanged their written closing submissions. The verdict was delivered on Jan 16, 2024. On June 4 of the same year, Dr Lee's registration was suspended for 18 months, and he was ordered to bear 80 per cent of the SMC's costs and 100 per cent of its spending, including the fees of its expert witnesses. However, in his appeal against this verdict, Dr Lee said the disciplinary tribunal's conclusions on the applicable standards of conduct were not supported by the evidence and that it had overlooked the various concessions given by a witness in his cross-examination. He also said MOH had not made clear whether the hormone therapy he used was prohibited, and it was therefore unjust to punish him for departing from the applicable standards of conduct when there was uncertainty on what was generally accepted by the medical profession. He felt that a letter of warning would be the appropriate sentence for him and set the motions for an appeal at the highest court in Singapore. Dr Lee was represented by Senior Counsel N Sreenivasan and lawyers Charles Lin, Tracia Lim and Daniel Poh from Charles Lin LLC for this appeal, while Senior Counsel Thio Shen Yi and lawyers R Arvindren and Ryan Yap from TSMP Law Corporation acted for the SMC. - The Straits Times/ANN
Borneo Post
6 days ago
- Borneo Post
KPJ Kuching completes 1,111th robotic-assisted knee replacement procedure
KPJ Kuching medical director Dr Mahadhir Alhady Sulaiman (third left), Dr Lee, KPJ Kuching general manager Nor Azlina Jemain and KPJ Healthcare Berhad regional chief executive officer of East Malaysia Dr Kenny take a group photo with representatives from Zimmer and Johnson & Johnson to celebrate the 1,111th procedure. KUCHING (July 6): KPJ Kuching Specialist Hospital has completed its 1,111th robotic-assisted Total Knee Replacement (TKR), marking a key milestone in the hospital's commitment to precision surgery and improved patient outcomes. The hospital in a statement on Saturday said this latest procedure reflects the hospital's sustained focus on clinical excellence and its leadership in robotic-assisted joint replacement within KPJ Healthcare. The achievement builds on its recent recognition as Orthopaedic Service Provider of the Year — Asia-Pacific 2025 at the GlobalHealth Asia-Pacific Awards, which acknowledged its innovation, surgical outcomes and patient care standards. The procedures are performed using the ROSA® Knee System by Zimmer Biomet and the VELYS™ Robotic-Assisted Solution by Johnson & Johnson. These systems enhance surgical accuracy, support faster recovery, and improve long-term mobility—particularly for patients with chronic knee pain or advanced osteoarthritis. KPJ Healthcare president and managing director Chin Keat Chyuan said the milestone at KPJ Kuching reflects the strength of the group's network-wide focus on quality, innovation, and subspecialty development. 'Under the KPJ Health System, we are advancing high-impact clinical programmes that deliver better outcomes for our patients. 'Guided by our purpose of Care for Life, we remain committed to expanding access to technology-driven, personalised care across our hospitals,' he said. Meanwhile, Consultant Orthopaedic Surgeon and pioneer of robotic knee surgery at KPJ Kuching Dr Lee Woo Guan said each knee represents a person regaining their ability to move confidently and live independently. 'Robotic technology like ROSA and VELYS has helped us personalise each procedure with greater precision and consistency, which directly translates into better outcomes and faster recovery for our patients,' he said. He added that the robotic programme has enabled KPJ Kuching to achieve lower complication rates, shorter hospital stays, and higher levels of patient satisfaction. 'More patients are now opting for robotic-assisted procedures as part of their care journey, particularly for improved mobility and long-term joint health,' he said. KPJ Healthcare continues to strengthen its investment in robotic technology, clinical leadership, and sub-specialty services as part of its transformation journey. These efforts align with the Group's strategy to integrate care delivery, education, and research, as well as to raise the overall standard of care across Malaysia. For more information, visit
Daily Express
6 days ago
- Daily Express
B40 Malaysians badly need basic health insurance plan
Published on: Sunday, July 06, 2025 Published on: Sun, Jul 06, 2025 By: Tan Sri Lee Lam Thye Text Size: A Basic Health Insurance Plan is not just a policy – it is an investment in the well-being and resilience of our nation. THE Alliance for a Safe Community fully supports the government's move to explore the introduction of a Basic Health Insurance Plan for all Malaysians. This is a long-overdue and much-needed initiative to ensure accessible, equitable, and affordable healthcare coverage, particularly for the B40 and vulnerable groups who remain underserved by the current health financing system. Advertisement In recent years, the cost of healthcare has continued to rise, making it increasingly difficult for low-income families to afford treatment for chronic illnesses, emergency care and preventive health services. A Basic Health Insurance Plan will provide much-needed financial protection for Malaysians, reduce out-of-pocket expenses, and prevent families from falling into poverty due to medical costs. We believe such a plan will also complement and strengthen our existing public healthcare system by promoting shared responsibility between the government and citizens, ensuring sustainable funding for healthcare, while enhancing access to quality care for all. However, the success of this initiative will depend heavily on transparency, inclusivity, and effective implementation. We urge the government to consider the following in designing the plan: Affordability and Accessibility – Premiums must be affordable, especially for the lower-income group. No one should be excluded due to financial constraints. Comprehensive Basic Coverage – The plan should include outpatient care, emergency treatment, preventive screenings, and chronic disease management. Simplicity and Clarity – The scheme must be easy to understand and navigate, avoiding unnecessary bureaucracy that may discourage enrolment. Government Subsidies for the Needy – There should be full or partial subsidies for those who are unemployed, elderly, disabled, or in the B40 category. Strong Regulatory Oversight – A robust monitoring mechanism is needed to ensure accountability, prevent abuse, and uphold the quality of care delivered under the scheme. Public engagement and education will also be vital to ensure that the population understands the purpose and benefits of the plan, and to build trust in its administration. We commend the government for this important step and look forward to a comprehensive plan that prioritises the health, dignity, and financial security of all Malaysians. A Basic Health Insurance Plan is not just a policy – it is an investment in the well-being and resilience of our nation. The views expressed here are the views of the writer and do not necessarily reflect those of the Daily Express. If you have something to share, write to us at: [email protected]
